BioRestorative Therapies, Inc. short interest in 2025
In 2025, BioRestorative Therapies, Inc.'s disclosed short interest ran from 1.88% of shares outstanding on 15 Jan 2025 to 1.54% on 31 Dec 2025, a change of -0.34 percentage points. The year's high was 5.85% on 14 Mar 2025 and its low 1.17% on 28 Nov 2025, averaging 2.36% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.68 days on 31 Mar 2025. Full history: BioRestorative Therapies, Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 1.88% (15 Jan 2025)
- End of year
- 1.54% (31 Dec 2025)
- Change
- -0.34 pp
- High
- 5.85% (14 Mar 2025)
- Low
- 1.17% (28 Nov 2025)
- Average
- 2.36%
- Highest days to cover
- 6.68 (31 Mar 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 1.88% | 2.38 | |
| 31 Jan 2025 | 3.40% | 2.71 | |
| 14 Feb 2025 | 3.38% | 3.24 | |
| 14 Mar 2025 | 5.85% | 5.76 | |
| 31 Mar 2025 | 4.39% | 6.68 | results (8-K), 10-K filed |
| 15 Apr 2025 | 2.76% | 5.34 | |
| 30 Apr 2025 | 2.30% | 6.57 | |
| 15 May 2025 | 2.18% | 5.61 | 10-Q filed, results (8-K) |
| 30 May 2025 | 1.89% | 5.80 | |
| 13 Jun 2025 | 3.48% | 1.00 | |
| 30 Jun 2025 | 2.71% | 2.05 | |
| 15 Jul 2025 | 2.28% | 1.50 | |
| 31 Jul 2025 | 2.07% | 1.72 | |
| 15 Aug 2025 | 1.91% | 5.85 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 1.86% | 1.00 | |
| 15 Sep 2025 | 1.41% | 2.20 | |
| 30 Sep 2025 | 1.42% | 2.13 | |
| 15 Oct 2025 | 1.56% | 1.37 | |
| 31 Oct 2025 | 1.73% | 1.00 | |
| 14 Nov 2025 | 1.61% | 5.01 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 1.17% | 1.00 | |
| 15 Dec 2025 | 1.40% | 4.01 | |
| 31 Dec 2025 | 1.54% | 3.36 |
See also: BioRestorative Therapies, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.